Table 1.
Comparison of frequency distributions and expected lifetime impacts for 19 cancers in Taiwan stratified by gender: LE after diagnosis, EYLL, lifetime cost, CIR0–79, and 95% CI
| Cancer | N | Age (years) (mean ± SD) |
CIR0–79a (%) |
LE after diagnosis (95% CI, years) |
EYLL (95% CI) (years) |
Lifetime cost (95% CI, ×103 USD) |
|---|---|---|---|---|---|---|
| Male | ||||||
| Liver | 99,659 | 60.9±13.4 | 6.66 | 4.7 (4.6–4.8) | 16.0 (15.8–16.1) | 23.0 (22.4–23.6) |
| Lung | 82,820 | 68.9±12.0 | 6.31 | 2.6 (2.5–2.7) | 12.6 (12.5–12.7) | 21.4 (21.1–21.8) |
| Colorectum | 80,425 | 65.7±13.3 | 6.79 | 10.9 (10.7–11.1) | 6.5 (6.3–6.7) | 40.4 (39.7–41.2) |
| Oral | 44,089 | 52.4±11.8 | 2.85 | 12.2 (11.7–12.6) | 15.0 (14.5–15.4) | 48.7 (47.3–50.1) |
| Esophagus | 22,504 | 59.1±12.4 | 1.64 | 3.1 (2.9–3.3) | 19.1 (18.8–19.3) | 25.9 (25.3–26.6) |
| Leukemia | 30,823 | 56.7±21.8 | 2.05 | 12.0 (11.3–12.6) | 13.0 (12.4–13.6) | 67.4 (64.5–70.2) |
| Stomach | 34,726 | 68.2±13.3 | 2.07 | 6.2 (6–6.4) | 9.5 (9.3–9.7) | 25.6 (24.9–26.3) |
| Nasopharynx | 16,758 | 50.3±13.1 | 0.85 | 14.3 (13.5–15.2) | 14.4 (13.6–15.3) | 48.9 (45.8–52.0) |
| Pancreas | 9,057 | 68.9±12.5 | 0.78 | 1.6 (1–2.1) | 15.2 (15–15.4) | 20.3 (10.6–30.1) |
| Prostate | 46,107 | 73.4±8.5 | 4.83 | 9.7 (9.5–9.8) | 2.4 (2.3–2.6) | 40.6 (39.6–41.5) |
| Intrahepatic bile ducts | 5,994 | 68.4±12.3 | 0.53 | 1.9 (1.5–2.3) | 16.0 (15.8–16.3) | 15.4 (14.5–16.3) |
| Bladder | 20,360 | 68.5±12.9 | 1.29 | 11.0 (10.6–11.4) | 4.6 (4.2–4.9) | 42.3 (40.8–43.7) |
| Kidney | 7,510 | 60.7±15.9 | 0.62 | 13.5 (12.5–14.5) | 7.7 (6.7–8.7) | 59.9 (54.5–65.2) |
| Renal pelvis and ureter | 6,425 | 66.4±12.3 | 0.55 | 9.1 (8.6–9.7) | 7.7 (7.2–8.3) | 54.0 (50.4–57.6) |
| Gallbladder and extrahepatic bile ducts | 3,096 | 67.3±13.9 | 0.24 | 3.2 (2.3–4) | 12.3 (11.8–12.8) | 20.3 (19.2–21.4) |
| Testis | 2,089 | 29.8±14.8 | 0.07 | 42.7 (39.4–45.9) | 4.2 (1.0–7.5) | 59.7 (50.9–68.4) |
| Female | ||||||
| Lung | 43,569 | 65.9±13.3 | 3.47 | 4.9 (4.6–5.2) | 15.1 (14.8–15.4) | 30.9 (29.6–32.3) |
| Breast | 101,550 | 52.4±12.2 | 6.77 | 23.7 (23.2–24.1) | 7.5 (7.1–8.0) | 69.9 (67.3–72.4) |
| Liver | 37,328 | 66.9±12.4 | 2.80 | 4.9 (4.8–5.1) | 14.0 (13.8–14.1) | 23.3 (22.5–24.0) |
| Colorectum | 60,075 | 65.1±14.2 | 4.47 | 13.1 (12.9–13.3) | 7.6 (7.4–7.9) | 42.3 (41.4–43.3) |
| Leukemia | 22,322 | 55.4±21.2 | 1.88 | 15.2 (14.4–16) | 14.1 (13.3–14.9) | 72.2 (68.4–76.0) |
| Stomach | 18,752 | 65.3±15.3 | 1.09 | 9.0 (8.5–9.4) | 11.7 (11.2–12.1) | 29.3 (27.8–30.7) |
| Ovary | 14,494 | 51.1±15.7 | 0.84 | 19.9 (19–20.7) | 12.7 (11.8–13.6) | 53.9 (50.7–57.0) |
| Pancreas | 6,350 | 68.1±13.1 | 0.56 | 1.8 (1.5–2.1) | 16.5 (16.1–16.9) | 14.6 (13.9–15.3) |
| Cervix | 31,613 | 56.2±14.6 | 1.17 | 21.3 (20.9–21.7) | 6.4 (6.0–6.8) | 45.6 (44.2–46.9) |
| Intrahepatic bile ducts | 5,219 | 67.0±12.1 | 0.41 | 1.8 (1.6–2.1) | 17.1 (16.8–17.4) | 14.5 (13.6–15.4) |
| Renal pelvis and ureter | 7,547 | 68.7±11.2 | 0.61 | 10.2 (9.6–10.8) | 7.3 (6.7–7.9) | 78.6 (72.4–84.7) |
| Nasopharynx | 5,591 | 49.7±13.7 | 0.25 | 18.3 (16.1–20.4) | 15.2 (13.0–17.4) | 51.1 (46.1–56.0) |
| Bladder | 8,034 | 68.4±12.7 | 0.49 | 10.9 (10.4–11.4) | 7.0 (6.5–7.5) | 69.2 (64.3–74.0) |
| Oral | 4,692 | 60.0±15.3 | 0.34 | 15.0 (13.6–16.4) | 10.0 (8.6–11.3) | 44.8 (40.1–49.6) |
| Gallbladder and extrahepatic bile ducts | 3,002 | 68.9±12.5 | 0.22 | 3.8 (3.2–4.3) | 13.8 (13.1–14.4) | 19.9 (18.5–21.2) |
| Kidney | 3,956 | 60.1±16.9 | 0.30 | 15.9 (14.3–17.5) | 9.0 (7.4–10.6) | 56 (47.8–64.1) |
| Esophagus | 1,755 | 67.3±13.9 | 0.12 | 4.3 (3.5–5.2) | 14.7 (13.7–15.7) | 23.6 (21.2–26.1) |
Notes:
a
CIR0–79 in 2010–2012.
Abbreviations: CIR0–79, cumulative incidence rate, aged 0–79; EYLL, expected years of life lost; LE, life expectancy.